Compass Capital Management’s Eli Lilly LLY Stock Holding History

Compass Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11.7M	Sell	12,735 -458	-3%	-$464K	0.71%	33
2025 Q4	$14.2M	Sell	13,193 -3,108	-19%	-$2.97M	0.79%	28
2025 Q3	$12.4M	Sell	16,301 -2,136	-12%	-$1.59M	0.66%	35
2025 Q2	$14.4M	Buy	18,437 +18,177	+6,991%	+$14.1M	0.77%	36
2025 Q1	$215K	Hold	260	–	–	0.01%	35
2024 Q4	$201K	Hold	260	–	–	0.01%	37
2024 Q3	$230K	Hold	260	–	–	0.01%	35
2024 Q2	$235K	Hold	260	–	–	0.02%	35
2024 Q1	$202K	Buy	+260	New	+$185K	0.01%	35

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Compass Capital Management's LLY Position: Q1 2026 in Review

Compass Capital Management reduced its Eli Lilly (LLY) stake by 3.5% in Q1 2026, selling an estimated $464K and leaving 12,735 shares worth $11.7M. The position accounts for 0.71% of the portfolio, ranked #33.

Compass Capital Management first reported a position in LLY in Q1 2024 and has held it in 9 quarters since. The position peaked at $14.4M in Q2 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Compass Capital Management held 12,735 shares of Eli Lilly worth $11.7M as of Q1 2026.
Compass Capital Management sold 458 Eli Lilly shares in Q1 2026, an estimated $464K.
Eli Lilly made up 0.71% of Compass Capital Management's portfolio in Q1 2026, its #33 holding.
Compass Capital Management first reported a position in Eli Lilly in Q1 2024 and has held it in 9 quarters since.
Compass Capital Management's Eli Lilly position peaked at $14.4M in Q2 2025.
4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Compass Capital Management's 13F filing for Q1 2026, filed 21 May 2026.